BackgroundGenetic variations in TGFB1 gene have been studied in relation to coronary heart disease (CHD) risk, but the results were inconsistent.MethodsWe performed a systematic review of published studies on the potential role of TGFB1 genetic variation in CHD risk. Articles that reported the association of TGFB1 genetic variants with CHD as primary outcome were searched via Medline and HuGE Navigator through July 2011. The reference lists from included articles were also reviewed.ResultsData were available from 4 studies involving 1777 cases and 7172 controls for rs1800468, 7 studies involving 5935 cases and 10677 controls for rs1800469, 7 studies involving 6634 cases and 9620 controls for rs1982073, 5 studies involving 5452 cases and 9999 controls for rs1800471, and 4 studies involving 5143 cases and 4229 controls for rs1800472. The pooled odds ratios (ORs) for CHD among minor T allele carriers of rs1800469, minor C allele carriers of rs1982073, and minor C allele carriers of rs1800471 versus homozygous major allele carriers was 1.14 (95% confidence interval [CI]: 1.05-1.24), 1.18 (95% CI: 1.04-1.35), and 1.16 (95% CI: 1.02-1.32), respectively. No substantial heterogeneity for ORs was detected among the included Caucasian populations for all SNPs. However, for rs1800471, the statistical significance disappeared after adjusting for potential publication bias. No significant association was found between rs1800468 and rs1800472 variants and CHD risk.ConclusionMinor allele carriers of two genetic variants (rs1800469 and rs1982073) in TGFB1 have a 15% increased risk of CHD.
BackgroundIn spite of progress in cardiovascular genetics, data on genetic background of myocardial infarction are still limited and contradictory. This applies as well to the genes involved in inflammation and coagulation processes, which play a crucial role in the disease etiopathogenesis.Methods and ResultsIn this study we found genetic variants of TGFB1, FGB and CRP genes associated with myocardial infarction in discovery and replication groups of Russian descent from the Moscow region and the Republic of Bashkortostan (325/185 and 220/197 samples, correspondingly). We also found and replicated biallelic combinations of TGFB1 with FGB, TGFB1 with CRP and IFNG with PTGS1 genetic variants associated with myocardial infarction providing a detectable cumulative effect. We proposed an original two-component procedure for the analysis of nonlinear (epistatic) interactions between the genes in biallelic combinations and confirmed the epistasis hypothesis for the set of alleles of IFNG with PTGS. The procedure is applicable to any pair of logical variables, e.g. carriage of two sets of alleles. The composite model that included three single gene variants and the epistatic pair has AUC of 0.66 both in discovery and replication groups.ConclusionsThe genetic impact of TGFB1, FGB, CRP, IFNG, and PTGS and/or their biallelic combinations on myocardial infarction was found and replicated in Russians. Evidence of epistatic interactions between IFNG with PTGS genes was obtained both in discovery and replication groups.
Carriage frequencies of alleles and genotypes of theTGFB1 gene
polymorphous loci –509C>T (rs1800469), 869T>C (rs1982073), 915G>C
(rs1800471), which affect the level of cytokine TGF-β1 production, were
analyzed in the patients of Russian ethnic descent with myocardial infarction
(MI) (406 cases) and in the control group of the same ethnic descent (198
controls). Significant association with MI was observed in carriage frequencies
of the alleleTGFB1*–509T (p=0.046, OR
=1.45, 95% CI: 1.02-2.06), genotypes TGFB1*869T/T
(p=0.0024, OR =1.75, 95% CI: 1.22-2.51),
andTGFB1*915G/G (p=0.048, OR=1.76, 95% CI:
1.05-2.97). Linkage disequilibrium analysis for these SNPs has shown that the
associations revealed can be considered to be independent. A complex analysis of
MI association with combinations of alleles/genotypes of said SNPs indicates
their cumulative effect. An analysis of susceptibility to early-onset MI
(≤ 50 years old) revealed a positive association of the
alleleTGFB1*–509T (p=0.002, OR=2.24,
95% CI: 1.35-3.71) and genotypeTGFB1*869T/T
(p=0.008, OR=1.93, 95% CI: 1.18-3.15), as well as their
additivity. An analysis of susceptibility to recurrent MI revealed an
association of the genotypeTGFB1*–509T/T
(p=0.0078, OR=2.60, 95% CI: 1.28-5.28). The results
obtained indicate the important role of theTGFB1gene in
susceptibility to MI, including early-onset and recurrent MI, in Russians.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.